Crossject reports successful completion of European and U.S. audits for manufacturing of ZENEO Midazolam for epileptic seizures
05.09.2023 - Press Release Crossject reports successful completion of European and U.S. audits for manufacturing of ZENEO Midazolam for epileptic seizures ISO 13485 certification renewed for manufacturing sites at Gray and Dijon French Health Agency ...
Source: wallstreet-online.de